NCT01847989
- Conditions
- Congenital Bleeding Disorder, Congenital FXIII Deficiency, Healthy
- Locations
-
- Novo Nordisk Investigational Site Berkshire, United Kingdom
Clinical trial condition
Congenital Bleeding Disorder
Explore clinical trials studying Congenital Bleeding Disorder. Study availability and eligibility vary by location and protocol.
85 public trials
0 recruiting studies
Congenital Bleeding Disorder trial results
NCT00056589
- Conditions
- Congenital Bleeding Disorder, Congenital FXIII Deficiency
- Locations
-
- Novo Nordisk Investigational Site Los Angeles, California, United States
NCT00703911
- Conditions
- Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
- Locations
-
- Novo Nordisk Investigational Site Algiers, Algeria
- Novo Nordisk Investigational Site Vienna, Austria
- Novo Nordisk Investigational Site Brussels, Belgium
- Novo Nordisk Investigational Site Prague, Czechia
NCT00882778
- Conditions
- Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
- Locations
-
- Novo Nordisk Investigational Site Princeton, New Jersey, United States
- Novo Nordisk Investigational Site Prov. de Buenos Aires, Argentina
- Novo Nordisk Investigational Site Mississauga, Canada
- Novo Nordisk Investigational Site Zagreb, Croatia
Completed
Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany
NCT00697320
- Conditions
- Acquired Bleeding Disorder, Acquired Haemophilia, Blood Coagulation Disorders, +11 more
- Locations
-
- Novo Nordisk Investigational Site Mainz, Germany
NCT01561924
- Conditions
- Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
- Locations
-
- Novo Nordisk Investigational Site Berkeley, California, United States
- Novo Nordisk Investigational Site Los Angeles, California, United States
- Novo Nordisk Investigational Site Iowa City, Iowa, United States
- Novo Nordisk Investigational Site Philadelphia, Pennsylvania, United States
NCT00710619
- Conditions
- Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors
- Locations
-
- Novo Nordisk Investigational Site Plainsboro, New Jersey, United States
NCT00853086
- Conditions
- Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +11 more
- Locations
-
- Novo Nordisk Investigational Site Crawley, United Kingdom
NCT01082406
- Conditions
- Congenital Bleeding Disorder, Congenital FXIII Deficiency, Healthy
- Locations
-
- Novo Nordisk Investigational Site Harrow, United Kingdom
NCT01253811
- Conditions
- Congenital Bleeding Disorder, Congenital FXIII Deficiency
- Locations
-
- Novo Nordisk Clinical Trial Call Center Boston, Massachusetts, United States
- Novo Nordisk Clinical Trial Call Center Columbus, Ohio, United States
- Petah Tikva, Israel
- Leicester, United Kingdom